Other OTC - Delayed Quote USD

RavenQuest BioMed Inc. (RVVQF)

0.0000 0.0000 (0.00%)
As of March 28 at 10:28 AM EDT. Market Open.
Loading Chart for RVVQF
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 3,550
  • Avg. Volume 0
  • Market Cap (intraday) 48,211
  • Beta (5Y Monthly) -105.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.

www.rqbglobal.com

--

Full Time Employees

October 31

Fiscal Year Ends

Related News

Performance Overview: RVVQF

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RVVQF
90.00%
S&P 500
6.32%

1-Year Return

RVVQF
90.00%
S&P 500
22.68%

3-Year Return

RVVQF
99.99%
S&P 500
22.64%

5-Year Return

RVVQF
100.00%
S&P 500
74.38%

Compare To: RVVQF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RVVQF

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    7.70

  • Enterprise Value/EBITDA

    -0.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.85%

  • Return on Equity (ttm)

    -112.46%

  • Revenue (ttm)

    1.52M

  • Net Income Avi to Common (ttm)

    -32.35M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    749.13k

  • Total Debt/Equity (mrq)

    71.99%

  • Levered Free Cash Flow (ttm)

    -3.3M

Company Insights: RVVQF

People Also Watch